Advertisement
A vs BRKR
Which Stock Would AI Choose? Agilent Technologies (A) vs. Bruker Corporation (BRKR) Stock Comparison
Key Takeaways
- Agilent Technologies (A) and Bruker Corporation (BRKR) both operate in the life sciences and analytical instruments sector, offering exposure to scientific research, diagnostics, and applied markets.
- Recent market activity shows Agilent (A) trading near $114.96 with modest monthly declines amid broader sector pressures, while Bruker (BRKR) has shown relative resilience around $45.69 following earnings beats.
- Agilent (A) reported first-quarter results that missed estimates but included raised full-year fiscal 2026 guidance and new product launches in trace element analysis.
- Bruker (BRKR) delivered first-quarter 2026 revenue growth of 2.7% year-over-year with non-GAAP EPS beating consensus and reconfirmed full-year outlook amid mentions of AI-related opportunities.
- Valuation and momentum metrics indicate trade-offs: Agilent (A) offers larger market capitalization and dividend yield, while Bruker (BRKR) trades at a lower absolute price point with potentially higher volatility.
- Sector sentiment remains tied to research funding, healthcare spending, and technological innovation, with both stocks reflecting measured investor positioning in recent weeks.
Introduction
Agilent Technologies (A) and Bruker Corporation (BRKR) represent two established players in the analytical and life sciences instrumentation space. Investors and traders seeking to compare relative performance often examine these names together due to overlapping end markets in research, diagnostics, and industrial applications. This comparison provides a factual overview of business profiles, recent price behavior, and key differentiators to assist those evaluating sector exposure or portfolio diversification within healthcare and technology equities. The analysis draws on observable market data and company disclosures without forward-looking assumptions.
Agilent Technologies (A) Overview and Recent Performance
Agilent Technologies (A) provides instruments, software, services, and consumables for life sciences, diagnostics, and applied chemical markets. In recent market activity, shares have traded near the lower end of the 52-week range of $107.07 to $160.27, reflecting a 1-month change of approximately -0.5%. Performance has been influenced by first-quarter fiscal 2026 earnings that missed consensus estimates alongside a raised full-year outlook and announcements of new products, including the Agilent 9500 Triple Quadrupole ICP-MS system. Broader sentiment has incorporated mixed industry demand signals, with the stock maintaining a dividend yield near 0.88% on a quarterly payout of $0.255 per share. Market capitalization stands around $21-32 billion depending on share count references.
Bruker Corporation (BRKR) Overview and Recent Performance
Bruker Corporation (BRKR) develops and manufactures scientific instruments and solutions for life science, materials research, and diagnostics applications. Recent trading has placed shares around $45.69 within a 52-week range of $28.53 to $56.22, with positive daily moves observed following earnings. First-quarter 2026 results showed revenue of $823.4 million, up 2.7% year-over-year, and non-GAAP EPS of $0.31 that exceeded estimates; the company reconfirmed full-year guidance of $3.57–$3.60 billion in revenue. Sentiment has incorporated commentary on AI-related growth areas alongside operational headwinds, with a recently declared quarterly dividend signaling management confidence. The smaller market capitalization relative to peers places emphasis on execution within niche instrumentation segments.
Trending AI Robots
Tickeron maintains a curated Trending AI Robots section that highlights select AI trading bots from a broader library of hundreds available across thousands of tickers. Only those demonstrating strong suitability for prevailing market conditions appear in this focused listing. Available bots span varied trading styles, strategies, timeframes, performance metrics, and ticker sets, with historical statistics typically including win rates, profit factors, and drawdown ranges that differ by bot. This diversity allows users to review objective performance data and alignment with specific instruments such as Agilent Technologies (A) or Bruker Corporation (BRKR). Review the full selection on the Trending AI Robots page for detailed comparisons.
Head-to-Head Comparison
Agilent Technologies (A) operates at larger scale with diversified exposure across life sciences and diagnostics, supporting steadier revenue streams but exposing it to wider cyclical demand fluctuations in applied markets. Bruker Corporation (BRKR) focuses more narrowly on high-performance analytical tools, potentially offering faster responsiveness to specialized research trends such as AI-enabled applications yet facing greater concentration risk. Recent momentum favors Bruker (BRKR) with earnings beats and guidance affirmation, contrasting Agilent’s (A) mixed quarterly results offset by product innovation and outlook upgrades. Risk factors include Agilent’s (A) higher absolute valuation multiples versus Bruker’s (BRKR) lower share price and potentially elevated volatility. Sector exposure overlaps significantly in life sciences instrumentation, with market sentiment reflecting shared sensitivity to research budgets and healthcare investment cycles. Trade-offs center on size and stability at Agilent (A) versus agility and niche positioning at Bruker (BRKR).
Tickeron AI Verdict
Based on observable factors including earnings consistency, recent price stability, and positioning within current market conditions, Tickeron’s AI models assign a probabilistic edge to Bruker Corporation (BRKR) for nearer-term trend alignment. This assessment reflects stronger relative earnings delivery and guidance maintenance compared with peer quarterly outcomes, alongside mentions of growth catalysts. However, outcomes remain subject to ongoing volatility in the sector, and no deterministic preference is implied.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and BRKR is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
A’s FA Score shows that 1 FA rating(s) are green whileBRKR’s FA Score has 1 green FA rating(s).
- A’s FA Score: 1 green, 4 red.
- BRKR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
A’s TA Score shows that 5 TA indicator(s) are bullish while BRKR’s TA Score has 7 bullish TA indicator(s).
- A’s TA Score: 5 bullish, 5 bearish.
- BRKR’s TA Score: 7 bullish, 4 bearish.
Price Growth
A (@Medical Specialties) experienced а +0.32% price change this week, while BRKR (@Medical/Nursing Services) price change was -0.12% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.93%. For the same industry, the average monthly price growth was +15.28%, and the average quarterly price growth was -5.41%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.34%. For the same industry, the average monthly price growth was +2.82%, and the average quarterly price growth was -15.23%.
Reported Earning Dates
A is expected to report earnings on Aug 18, 2026.
BRKR is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Medical Specialties (-0.93% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-0.34% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| A | BRKR | A / BRKR | |
| Capitalization | 38.3B | 8.71B | 440% |
| EBITDA | 1.96B | 306M | 641% |
| Gain YTD | -0.028 | 21.685 | -0% |
| P/E Ratio | 27.20 | 74.88 | 36% |
| Revenue | 7.23B | 3.46B | 209% |
| Total Cash | 1.81B | 133M | 1,359% |
| Total Debt | 3.36B | 1.67B | 201% |
A | BRKR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 38 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 49 Fair valued | |
PROFIT vs RISK RATING 1..100 | 89 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 44 | 38 | |
P/E GROWTH RATING 1..100 | 57 | 5 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
A's Valuation (6) in the Biotechnology industry is somewhat better than the same rating for BRKR (49) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BRKR’s over the last 12 months.
A's Profit vs Risk Rating (89) in the Biotechnology industry is in the same range as BRKR (100) in the Medical Specialties industry. This means that A’s stock grew similarly to BRKR’s over the last 12 months.
A's SMR Rating (100) in the Biotechnology industry is in the same range as BRKR (100) in the Medical Specialties industry. This means that A’s stock grew similarly to BRKR’s over the last 12 months.
BRKR's Price Growth Rating (38) in the Medical Specialties industry is in the same range as A (44) in the Biotechnology industry. This means that BRKR’s stock grew similarly to A’s over the last 12 months.
BRKR's P/E Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for A (57) in the Biotechnology industry. This means that BRKR’s stock grew somewhat faster than A’s over the last 12 months.
| A | BRKR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 1 day ago 62% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 61% | 3 days ago 64% |
| MACD ODDS (%) | 1 day ago 60% | 3 days ago 71% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 72% |
| TrendMonth ODDS (%) | 1 day ago 58% | 1 day ago 73% |
| Advances ODDS (%) | 7 days ago 60% | 13 days ago 69% |
| Declines ODDS (%) | 3 days ago 63% | 3 days ago 72% |
| BollingerBands ODDS (%) | 1 day ago 63% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 68% |
Advertisement